Just read a nice Q&A article from Murtuza Bharmal on the increased use of RWD/RWE.

The point he makes on "ensuring minimal missing data" is certainly critical to the external validity of real world ...

ISPOR’s Value and Outcomes Spotlight recent Sep/Oct 2020 issue contained an interesting Q&A article with Jennifer Graff (VP, Comparative-Effectiveness Research, National Pharmaceutical Council). Overall, it was interesting, ...